ACT(ACT)
ACT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $1.26B | $1.28B | $1.30B |
| Low | $1.25B | $1.26B | $1.24B |
| High | $1.28B | $1.29B | $1.34B |
| EBITDA Avg | $985M | $1.05B | $1.10B |
| Low | $971M | $1.01B | $1.08B |
| High | $1000M | $1.09B | $1.12B |
| EBIT Avg | $909M | $960M | $996M |
| Low | $895M | $922M | $979M |
| High | $924M | $998M | $1.01B |
| Net Income Avg | $713M | $753M | $781M |
| Low | $702M | $723M | $768M |
| High | $724M | $782M | $794M |
| EPS Avg | $4.80 | $5.03 | $5.23 |
| Low | $4.70 | $4.84 | $5.14 |
| High | $4.85 | $5.24 | $5.31 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 3 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $317M | $317M | $318M | $320M | $321M | $322M | $318M | $320M |
| Low | $316M | $316M | $317M | $319M | $321M | $321M | $317M | $319M |
| High | $318M | $318M | $319M | $321M | $323M | $323M | $320M | $322M |
| EBITDA Avg | $228M | $228M | $245M | $253M | $246M | $236M | $260M | $263M |
| Low | $226M | $227M | $244M | $252M | $245M | $235M | $259M | $262M |
| High | $229M | $229M | $246M | $254M | $247M | $237M | $261M | $264M |
| EBIT Avg | $212M | $211M | $227M | $234M | $225M | $215M | $238M | $240M |
| Low | $210M | $210M | $226M | $233M | $225M | $214M | $237M | $239M |
| High | $213M | $212M | $228M | $235M | $227M | $216M | $239M | $241M |
| Net Income Avg | $166M | $165M | $178M | $183M | $177M | $168M | $187M | $188M |
| Low | $165M | $165M | $177M | $182M | $176M | $168M | $186M | $187M |
| High | $167M | $166M | $179M | $184M | $178M | $169M | $188M | $189M |
| EPS Avg | $1.18 | $1.18 | $1.27 | $1.30 | $1.26 | $1.20 | $1.33 | $1.34 |
| Low | $1.17 | $1.17 | $1.26 | $1.30 | $1.26 | $1.20 | $1.33 | $1.34 |
| High | $1.19 | $1.18 | $1.27 | $1.31 | $1.27 | $1.21 | $1.34 | $1.35 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |